Muscle Invasive Bladder Carcinoma — Trials

Muscle Invasive Bladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 34
Recruiting: 22
Ph III recruiting: 4
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04383743	Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer	completed	Phase 2	17	University of WashingtonOTHER	1	Sep 18, 2025	clinicaltrials
NCT03617913	Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer	completed	Phase 2	2	Mayo ClinicOTHER	1	Jan 6, 2023	clinicaltrials